ArticleCancers2021

Lower Survival and Increased Circulating Suppressor Cells in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma with Deficit of Vitamin D Levels Using R-GDP Plus Lenalidomide (R2-GDP): Results from the R2-GDP-GOTEL Trial.

Carlos Jiménez-Cortegana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.